These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Botulinum toxin type A and B primary resistance. Dobryansky M; Korsh J; Shen AE; Aliano K Aesthet Surg J; 2015 Feb; 35(2):NP28-30. PubMed ID: 25653242 [No Abstract] [Full Text] [Related]
69. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections? Johns Hopkins Med Lett Health After 50; 2014 Jul; 26(6):7. PubMed ID: 25178125 [No Abstract] [Full Text] [Related]
70. Quantitative evaluation of the onset and longevity of the action of incobotulinumtoxinA by skin displacement analysis in the treatment of glabellar frown lines. Proebstle TM; Chung G; Weissberg R; Pavicic T J Drugs Dermatol; 2014 Sep; 13(9):1067-72. PubMed ID: 25226007 [TBL] [Abstract][Full Text] [Related]
71. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Brandt F; Swanson N; Baumann L; Huber B Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186 [TBL] [Abstract][Full Text] [Related]
73. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A. Mannava S; Plate JF; Stone AV; Smith TL; Smith BP; Koman LA; Tuohy CJ J Hand Surg Am; 2011 Oct; 36(10):1708-10. PubMed ID: 21903346 [No Abstract] [Full Text] [Related]
74. Botulinum neurotoxins and injectable fillers: minimally invasive management of the aging upper face. Maas CS Facial Plast Surg Clin North Am; 2006 Aug; 14(3):241-5. PubMed ID: 16908391 [No Abstract] [Full Text] [Related]
75. Commentary on Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines. Lawrence N Dermatol Surg; 2015 Jun; 41(6):718-9. PubMed ID: 25993610 [No Abstract] [Full Text] [Related]
76. Multicentre, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines. Fulford-Smith A; Gallagher CJ; Brin MF Dermatol Surg; 2013 Jul; 39(7):1118-9. PubMed ID: 23725480 [No Abstract] [Full Text] [Related]
77. Improving Patient Satisfaction and Quality of Care During Aesthetic Use of Botulinum Toxin. Council ML JAMA Dermatol; 2015 Nov; 151(11):1179-80. PubMed ID: 26352936 [No Abstract] [Full Text] [Related]
79. Assessment of Botulinum Toxin Aesthetic Outcomes: Clinical Study vs Real-World Practice. Glogau R; Biesman B; Kane M JAMA Dermatol; 2015 Nov; 151(11):1177-8. PubMed ID: 26375723 [No Abstract] [Full Text] [Related]
80. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation. Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]